WO1996035673A1 - 1-fluor-6,7-dihydro-5h-isochinolin-8-on-derivate und ihre verwendung in flüssigkristallinen mischungen - Google Patents
1-fluor-6,7-dihydro-5h-isochinolin-8-on-derivate und ihre verwendung in flüssigkristallinen mischungen Download PDFInfo
- Publication number
- WO1996035673A1 WO1996035673A1 PCT/EP1996/001990 EP9601990W WO9635673A1 WO 1996035673 A1 WO1996035673 A1 WO 1996035673A1 EP 9601990 W EP9601990 W EP 9601990W WO 9635673 A1 WO9635673 A1 WO 9635673A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ich
- phe
- pyr
- pym
- naf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
- C09K19/3444—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
Definitions
- optically active, inclined smectic (ferroelectric) liquid crystals have also recently been used in commercial display devices.
- connection that form inclined or orthogonal smectic phases and are themselves optically active, or one can by doping compounds that form such smectic phases, but not optically active are, induce ferroelectric smectic phases with optically active compounds.
- the desired phase should be stable over the largest possible temperature range.
- a uniform planar orientation of the liquid crystals is necessary to achieve a good contrast ratio in electro-optical components.
- a good orientation in the S A and S * c phase can be achieved, for example, if the phase sequence of the liquid crystal mixture with decreasing temperature is: Isotropic ⁇ N * ⁇ S A ⁇ S * c
- the pitch (pitch of the helix) in the N * phase is very large (greater than 10 ⁇ m) or, even better, completely compensated (see, for example, T. Matsumoto et al., P. 468-470, Proc. of the 6th Int. Display Research Conf., Japan Display, Sept. 30 - Oct. 2, 1986, Tokyo, Japan; M. Murakami et al., ibid. pp. 344 - p. 347).
- the pitch in the smectic C * phase is significantly greater than the thickness of the display element (Mol. Cryst. Liq. Cryst. 94 (1 983) 21 3-134 and 1 14 (1 984) 1 51 -1 87). This is achieved, as in the case of cholesteric pitch, by using dopants with the helix rotating in the opposite direction.
- the optical switching time r [ps] of ferroelectric liquid crystal systems which should be as short as possible, depends on the rotational viscosity of the system y [mPas], the spontaneous polarization P s [nC / cm 2 ] and the electric field strength EtV / m] according to the relationship
- the ferroelectric display medium Since the field strength E is determined by the electrode spacing in the electro-optical component and by the voltage applied, the ferroelectric display medium must be of low viscosity and have a high spontaneous polarization so that a short switching time is achieved. Finally, in addition to thermal, chemical and photochemical stability, a small optical anisotropy ⁇ , preferably “0, 13, and a low positive or preferably negative dielectric anisotropy A ⁇ is required (see, for example, ST Lagerwall et al.,” Ferroelectric Liquid Crystals for Displays " SID Symposium, Oct. Meeting 1985, San Diego, Ca, USA). All of these requirements can only be met with mixtures of several components.
- the basis (or matrix) used is preferably compounds which, if possible, themselves already have the desired phase sequence 1 ⁇ N ⁇ S A ⁇ S c .
- Other components of the mixture are often added to lower the melting point and broaden the S c - and usually also the N phase, to induce optical activity, to compensate for pitch and to adapt the optical and dielectric anisotropy, but, for example, do not increase the rotational viscosity if possible shall be.
- the DHF effect was described by Bl Ostrovski in Advances in Liquid Crystal Research and Applications, Oxford / Budapest 1980, 469 ff.,
- the PSFLCD effect is described in DE-A 39 20 625 and EP-A 0 405 346.
- a liquid crystal material with a short S c pitch is required to use these effects.
- the object of the present invention was therefore to provide new compounds which are suitable in liquid-crystalline mixtures for improving the property profile of these mixtures.
- the invention therefore relates to compounds of the formula (I)
- R 1 , R 2 are identical or different hydrogen, -CN, -F, -Cl, -CF 3 ,
- -CHF 2 CH-, -C ⁇ C-, Cyclopropan-1, 2-diyl, -Si (CH 3 ) 2 -, 1, 4-phenylene, trans-1, 4-cyclohexylene or trans-1, 3-cyclopentylene can be replaced, with the proviso that oxygen atoms and / or Sulfur atoms must not be bonded directly to one another, and / or one or more H atoms of the alkyl radical may be substituted by -F, -Cl, -Br, -
- M 1 , M 2 , M 3 , M 4 , M 5 , M 6 are identical or different -O-, -S-, -CO-, -CO-O-,
- a 1 , A 2 , A 3 , A 4 are identical or different 1, 4-phenylene, where one or more H atoms can be replaced by F, Cl and / or CN, pyrazine-2,5-diyl, one or two H atoms can be replaced by F, Cl and / or CN, pyridazine-3,6-d
- a, b, c, d, e, f are zero or one, with the proviso that the sum of b, c, d and e must be 0, 1 or 2.
- the compounds of the formula (I) are colorless in the pure state and generally form liquid-crystalline mesophases in a temperature range which is favorable for electro-optical use. They are stable chemically, thermally and against light.
- the compounds of formula (I) are particularly suitable for influencing the dielectric anisotropy ⁇ of liquid-crystalline mixtures in the direction of higher negative values even in small amounts.
- Preferred compounds of the general formula (I) are those in which the symbols and indices have the following meanings:
- R 1 , R 2 are identical or different hydrogen, -CN, -F, -Cl, -CF 3 ,
- -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F or a straight-chain or branched alkyl radical having 1 to 18 carbon atoms (with or without an asymmetric carbon atom), one or more CH 2 - groups by -O-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, -CH CH-, -C ⁇ C-, cyclopropane-1, 2- diyl, -Si (CH 3 ) 2 - or trans-1, 4-cyclohexylene can be replaced, with the proviso that oxygen atoms must not be bonded directly to one another, and / or where one or more H atoms of the alkyl radical are replaced by -F , -Cl, -OR 3 , -OCN or -N 3 may be substituted, or one of the following groups (optically active or racemic): n 5
- a 1 , A 2 , A 3 , A 4 are identical or different 1, 4-phenylene, where one or more H atoms can be replaced by F, Cl and / or CN, pyrazine-2,5-diyl, one or two H atoms can be replaced by F, Cl and / or CN, pyridazine-3,6-diyl, where one or two H atoms can be replaced by F, Cl and / or CN, pyridine-2,5- diyl, where one or more H atoms can be replaced by F, Cl and / or CN, pyrimidine-2,5-diyl, where one or two H atoms can be replaced by F, Cl and / or CN, trans- 1, 4-cyclohexylene, where one or two H atoms can be replaced by CN and / or CH 3 , (1, 3,4) -Thiadiazol-2,5-diyl, 1, 3-dioxane-2,5- diyl,
- a, b, c, d, e, f are zero or one, with the proviso that the sum of b, c, d and e is 0, 1 or 2.
- R 1 , R 2 are identical or different hydrogen, -CN, -F, -Cl, -CF 3 ,
- -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F or a straight-chain or branched alkyl radical with 1 to 16 carbon atoms (with or without asymmetric carbon atom), also one, two or three CH 2 - Groups by -O-, -CO-, -O-CO-, -CO-O-, -CH CH-, cyclopropane-1, 2-diyl, -Si (CH 3 ) 2 - or trans-1, 4 -Cyclohexylene can be replaced, with the proviso that oxygen atoms must not be bonded directly to one another, and / or wherein one or more H atoms of the alkyl radical can be substituted by -F, -Cl or -OR 3 , or one of the following Groups (optically active or racemic):
- M 1 , M 2 , M 3 , M 4 , M 5 , M 6 are identical or different -O-, -CO-, -CO-O-,
- a 1 , A 2 , A 3 , A 4 are identical or different 1, 4-phenylene, where one, two or three H atoms can be replaced by F, Cl and / or CN, pyridine-2,5-diyl, where one or two H atoms can be replaced by F, Cl and / or CN, pyrimidine-2,5-diyl, where one or two H atoms can be replaced by F, Cl and / or CN, trans-1, 4-cyclohexylene, where one or two H atoms can be replaced by CN and / or CH 3 , (1, 3,4) -thiadiazole-2,5-diyl or naphthalene-2,6-diyl, one or two H atoms can be replaced by F, Cl and / or CN;
- a, b, c, d, e, f are zero or one, with the proviso that the sum of b, c, d and e is 0, 1 or 2.
- R 1 , R 2 are the same or different hydrogen or a straight-chain or branched alkyl radical with 1 to 12 carbon atoms (with or without an asymmetric carbon atom), one, two or three CH 2 groups also being represented by -O-, - O-CO-, -CO-O- or trans-1, 4-cyclohexylene can be replaced, with the proviso that oxygen atoms must not be bonded directly to one another, and / or where one or more H atoms of the alkyl radical are substituted by -F can be substituted, or one of the following groups (optically active or racemic):
- R 3 , R 4 are the same or different hydrogen or a straight chain
- Alkyl radical with 1 -9 carbon atoms it also being possible for one or more CH 2 groups to be replaced by —O—, with the proviso that oxygen atoms must not be bonded directly to one another;
- M 1 , M 2 , M 3 , M 4 , M 5 , M 6 are identical or different -O-, -CO-, -CO-O-,
- a 1 , A 2 , A 3 , A 4 are identical or different 1, 4-phenylene, where one, two or three H atoms can be replaced by F, pyridine-2,5-diyl, where one or two H- Atoms can be replaced by F, pyrimidine-2,5-diyl, trans-1, 4-cyclohexylene, where one or two H atoms can be replaced by CN and / or CH 3 or naphthalene-2,6-diyl, where one or two H atoms can be replaced by F; a, b, c, d, e, f are zero or one, with the proviso that the sum of b, c, d and e is 0, 1 or 2.
- TDZ (1, 3,4) -Thiadiazol-2,5-diyl and M 1 , M 6 , R 1 , R 2 are those given in the formula (I). Have meanings.
- the compounds according to the invention are prepared by methods known per se from the literature, as described in standard works on organic synthesis, e.g. Houben-Weyl, Methods of Organic Chemistry, Georg-Thieme-Verlag, Stuttgart.
- the preparation takes place under reaction conditions which are known and suitable for the reactions mentioned. Use can also be made here of variants which are known per se and are not mentioned here in detail.
- the starting materials can also be formed in situ, in such a way that they are not isolated from the reaction mixture, but instead are immediately reacted further to give the compounds of the formula (I).
- the group P 9 is the grouping R 1 (-M 1 ) a (-A 1 -M 2 ) b (-A 2 -M 3 ) c or a suitable, optionally protected precursor thereof, which is known per se in later steps , methods familiar to the person skilled in the art can be transferred into this grouping.
- P 9 can be a perfluoroalkyl sulfonate, the group R 1 (-M 1 ) a (-A 1 -M 2 ) b (-A 2 -M 3 ) c then being introduced by coupling with, for example, a corresponding boronic acid.
- R x is the grouping (-M 4 -A 3 ) d (-M 5 -A 4 ) e (-M 6 ) f -R 2 or a suitable, possibly protected precursor thereof, which in later steps according to known, methods familiar to the person skilled in the art can be converted into this grouping.
- the preparation takes place under reaction conditions which are known and suitable for the reactions mentioned. Use can also be made here of variants which are known per se and are not mentioned here in detail.
- DE-A 26 41 724 for compounds with pyrimidine-2,5-diyl groups;
- DE-A 40 26 223 and EP-A 03 91 203 for compounds with pyridine-2,5-diyl groups;
- DE-A 32 31 462 for compounds with pyridazine-3,6-diyl groups; EP-A 309 514 for compounds with (1, 3,4) thiadiazole-2-5-diyl groups;
- WO-A 92/1 6500 for naphthalene-2,6-diyl groups;
- DE-A 37 10 890 for bicyclo [2.2.2.] Octane-1,4-diyl groups;
- K. Seto et al Journal of the Chemical Society, Chemical Communications 1 988,
- disubstituted pyridines disubstituted pyrazines, disubstituted pyrimidines and disubstituted pyridazines
- disubstituted pyridines disubstituted pyrazines
- disubstituted pyrimidines disubstituted pyridazines
- Dioxane derivatives are expediently prepared by reacting an appropriate aldehyde (or one of its reactive derivatives) with a corresponding 1,3-diol (or one of its reactive derivatives), preferably in the presence of an inert solvent, such as benzene or toluene, and / or a catalyst,
- an inert solvent such as benzene or toluene
- a catalyst for example, a strong acid such as sulfuric acid, benzene or p-toluenesulfonic acid, at temperatures between about 20 ° C and about 1 50 ° C, preferably between 80 ° C and 1 20 ° C.
- Acetals are primarily suitable as reactive derivatives of the starting materials.
- aldehydes and 1,3-diols mentioned and their reactive derivatives are known, and in some cases they can be prepared without difficulty from standard compounds of organic chemistry from compounds known from the literature.
- the aldehydes can be obtained by oxidation of corresponding alcohols or by reduction of nitriles or corresponding carboxylic acids or their derivatives, and the diols can be obtained by reducing corresponding diesters.
- Compounds in which an aromatic ring is substituted by at least one F atom can also be obtained from the corresponding diazonium salts by exchanging the diazonium group for a fluorine atom, e.g. according to the methods of Balz and Schiemann.
- Suitable reactive derivatives of the carboxylic acids mentioned are in particular the acid halides, especially the chlorides and bromides, and also the anhydrides, e.g. also mixed anhydrides, azides or esters, especially alkyl esters with 1 -4 C atoms in the alkyl group.
- Suitable reactive derivatives of the alcohols or phenols mentioned are in particular the corresponding metal alcoholates or phenolates, preferably an alkali metal, such as sodium or potassium.
- esterification is advantageously carried out in the presence of an inert solvent.
- Ethers such as diethyl ether, di-n-butyl ether, THF (tetrahydrofuran), dioxane or anisole, ketones such as acetone, butanone or cyclohexanone, amides such as DMF or are particularly suitable
- Phosphoric acid hexamethyl triamide Phosphoric acid hexamethyl triamide
- hydrocarbons such as benzene, toluene or xylene
- halogenated hydrocarbons such as carbon tetrachloride, dichloromethane or tetrachlorethylene
- sulfoxides such as dimethyl sulfoxide or sulfolane.
- Ethers of the formula (I) can be obtained by etherification of corresponding hydroxyl compounds, preferably corresponding phenols, the hydroxyl compound advantageously first being converted into a corresponding metal derivative, for example by treatment with NaH, NaNH 2 , NaOH, KOH, Na 2 CO 3 or K 2 CO 3 is converted into the corresponding alkali metal alcoholate or alkali metal phenolate.
- the compounds of formula (I) have a wide range of uses. Depending on the selection of the substituents, they can serve as base materials from which liquid-crystalline phases are predominantly composed; However, it is also possible to add compounds of the formula (I) to liquid-crystalline base materials from other classes of compounds in order, for example, to influence the dielectric and / or optical anisotropy of such a dielectric and / or to optimize its threshold voltage and / or its viscosity.
- the invention also relates to the use of compounds of the formula (I) in liquid-crystal mixtures, preferably ferroelectric and nematic, in particular ferroelectric.
- the invention furthermore relates to liquid crystal mixtures, preferably ferroelectric and nematic, in particular ferroelectric, comprising one or more compounds of the formula (I).
- the liquid crystal mixtures according to the invention generally contain 2 to 35, preferably 2 to 25, particularly preferably 2 to 20 components.
- They generally contain 0.01 to 80% by weight, preferably 0.1 to 60% by weight, particularly preferably 0.1 to 30% by weight, of one or more, preferably 1 to 10, particularly preferably 1 to 5, very particularly preferably 1 to 3, of the compounds of the formula (I) according to the invention.
- liquid crystal mixtures which contain compounds of the formula (I) according to the invention are preferably selected from the known compounds with smectic and / or nematic and / or cholesteric phases. These include e.g. B .:
- Phenylbenzoates such as from P. Keller, Ferroelectrics 58
- optically active phenylbenzoates as described, for example, by P. Keller, Ferroelectrics 58 (1984), 3 and JW Goodby et al., Liquid Crystals and Ordered Fluids, Vol. 4, New York 1 984, optically active oxirane ethers, such as in EP-A 0 263 437 and
- WO-A 93/13093 describes optically active oxirane esters, as described, for example, in EP-A 0 292 954, optically active dioxolane ethers, as described for example in EP-A 0 351 746, optically active dioxolane esters, as described for example in EP-A 0 361 272, optically active tetrahydrofuran-2-carboxylic acid esters, such as in
- EP-A 0 355 561, and optically active 2-fluoroalkyl ethers as described for example in EP-A 0 237 007 and US-A 5,051, 506.
- the mixtures in turn can be used in electro-optical or completely optical elements, e.g. B. display elements, switching elements, light modulators, elements for image processing and / or signal processing or generally in the field of non-linear optics.
- Liquid-crystalline mixtures which contain compounds of the general formula (I) are particularly suitable for use in electro-optical switching and display devices (displays). These displays are usually constructed in such a way that a liquid crystal layer is enclosed on both sides by layers which, starting from the LC layer, are usually at least one orientation layer, electrodes and a boundary plate (eg made of glass). They also contain spacers, adhesive frames, polarizers and thin color filter layers for color displays. Other possible components are antireflection, passivation, compensation and barrier layers as well as electrically non-linear elements, such as thin-film transistors (TFT) and metal-insulator-metal (MIM) elements.
- TFT thin-film transistors
- MIM metal-insulator-metal
- mixtures for field treatment i.e. H. suitable for operation in quasi-bookshelf geometry (QBG) (see, for example, H. Rieger et al., SID 91 Digest (Anaheim) 1991, 396).
- QBG quasi-bookshelf geometry
- the compounds of formula (I) can also be used as components of antiferroelectric liquid crystal mixtures.
- 1-fluoro-3- (4-hydroxy-phenyl) -7-alkyl-6,7-dihydro-5H-isoquinolin-8-ones can be combined with further alkyl halides, sulfonic acid-2-fluoroalkyl esters, sulfonic acid-2, Implement 3-difluoroalkyl esters, sulfonic acid 3-alkyl-oxirane-2-methyl esters, ( ⁇ -bromo-alkylJ-cyclopropanes or 1-bromo-dimethylsilanylalkanes.
- Example 3 1-fluoro-7- (5-hydroxy-pyrimidin-2-yl) -3-alkyloxy-6,7-dihydro-5H-isoquinolin-8-one with sulfonic acid-2-fluoroalkyl esters, sulfonic acid Implement -2,3-difluoroalkyl esters, sulfonic acid-3-alkyl-oxirane-2-methyl esters, ( ⁇ -bromo-alkyl) -cyclopropanes or 1-bromo-dimethylsilanylalkanes.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Plural Heterocyclic Compounds (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8533777A JPH11505529A (ja) | 1995-05-10 | 1996-05-10 | 1−フルオロ−6,7−ジヒドロ−5h−イソキノリン−8−オン誘導体およびその液晶混合物における使用 |
US08/952,054 US5874023A (en) | 1995-05-10 | 1996-05-10 | 1-Fluoro-6,7-dihydro-5H-isoquinolin-8-one derivatives and the use in liquid crystalline mixtures |
EP96916034A EP0824521B1 (de) | 1995-05-10 | 1996-05-10 | 1-fluor-6,7-dihydro-5h-isochinolin-8-on-derivate und ihre verwendung in flüssigkristallinen mischungen |
DE59603787T DE59603787D1 (de) | 1995-05-10 | 1996-05-10 | 1-fluor-6,7-dihydro-5h-isochinolin-8-on-derivate und ihre verwendung in flüssigkristallinen mischungen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19517051A DE19517051A1 (de) | 1995-05-10 | 1995-05-10 | 1-Fluor-6,7-dihydro-5H-isochinolin-8-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
DE19517051.2 | 1995-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996035673A1 true WO1996035673A1 (de) | 1996-11-14 |
Family
ID=7761505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1996/001990 WO1996035673A1 (de) | 1995-05-10 | 1996-05-10 | 1-fluor-6,7-dihydro-5h-isochinolin-8-on-derivate und ihre verwendung in flüssigkristallinen mischungen |
Country Status (6)
Country | Link |
---|---|
US (1) | US5874023A (de) |
EP (1) | EP0824521B1 (de) |
JP (1) | JPH11505529A (de) |
KR (1) | KR19990008462A (de) |
DE (2) | DE19517051A1 (de) |
WO (1) | WO1996035673A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19652246A1 (de) * | 1996-12-16 | 1998-06-18 | Hoechst Ag | 5,7-Difluor-3,4-dihydro-2H-naphthalin-1-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
EP1814551A2 (de) * | 2004-09-20 | 2007-08-08 | Xenon Pharmaceuticals Inc. | Pyridazin-derivate zur verhinderung menschlicher stearoyl-coa-desaturase |
TW200626139A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
BRPI0515488A (pt) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de heterocìclicos e seu uso como agentes terapêuticos |
AR051294A1 (es) * | 2004-09-20 | 2007-01-03 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
TW200626572A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
WO2006034440A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
WO2006034446A2 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
MX2007003332A (es) * | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa. |
EP2540296A1 (de) * | 2005-06-03 | 2013-01-02 | Xenon Pharmaceuticals Inc. | Arminothiazolderivate als menschliche Stearoyl-Coa-Desaturase-Hemmer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992011241A1 (de) * | 1990-12-19 | 1992-07-09 | Hoechst Aktiengesellschaft | 2-fluorpyridine, verfahren zu ihrer herstellung und ihre verwendung in flüssigkristallmischungen |
EP0643119A1 (de) * | 1993-08-03 | 1995-03-15 | Sumitomo Chemical Company, Limited | Trans-Olefinverbindungen, Verfahren zu deren Herstellung, Flüssigkristallzusammensetzung enthaltend derartige Verbindungen und Flüssigkristallelement zur Verwendung der Zusammensetzung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
DE69522986T2 (de) * | 1994-03-25 | 2002-04-04 | Canon Kk | Mesomorphische Verbindung, Flüssigkristallzusammensetzung die sie enthält, Flüssigkristallvorrichtung, -apparat und Anzeigevorrichtung diese Zusammensetzung verwendend |
-
1995
- 1995-05-10 DE DE19517051A patent/DE19517051A1/de not_active Withdrawn
-
1996
- 1996-05-10 JP JP8533777A patent/JPH11505529A/ja active Pending
- 1996-05-10 US US08/952,054 patent/US5874023A/en not_active Expired - Fee Related
- 1996-05-10 DE DE59603787T patent/DE59603787D1/de not_active Expired - Lifetime
- 1996-05-10 KR KR1019970707992A patent/KR19990008462A/ko not_active Application Discontinuation
- 1996-05-10 EP EP96916034A patent/EP0824521B1/de not_active Expired - Lifetime
- 1996-05-10 WO PCT/EP1996/001990 patent/WO1996035673A1/de not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992011241A1 (de) * | 1990-12-19 | 1992-07-09 | Hoechst Aktiengesellschaft | 2-fluorpyridine, verfahren zu ihrer herstellung und ihre verwendung in flüssigkristallmischungen |
EP0643119A1 (de) * | 1993-08-03 | 1995-03-15 | Sumitomo Chemical Company, Limited | Trans-Olefinverbindungen, Verfahren zu deren Herstellung, Flüssigkristallzusammensetzung enthaltend derartige Verbindungen und Flüssigkristallelement zur Verwendung der Zusammensetzung |
Non-Patent Citations (1)
Title |
---|
YOKOYAMA A ET AL: "6-Alkyl-2-(4-alkyloxyphenyl)quinoline: a new smectic C base material***", FERROELECTRICS (FEROA8,00150193);93; VOL.148 (1-4); PP.139-45, NIKKO KYODO CO., LTD.;PET. LAB.; TODA; 335; JAPAN (JP), XP000578754 * |
Also Published As
Publication number | Publication date |
---|---|
US5874023A (en) | 1999-02-23 |
KR19990008462A (ko) | 1999-01-25 |
DE59603787D1 (de) | 2000-01-05 |
EP0824521A1 (de) | 1998-02-25 |
DE19517051A1 (de) | 1996-11-14 |
JPH11505529A (ja) | 1999-05-21 |
EP0824521B1 (de) | 1999-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0825987B1 (de) | 1-fluorisochinolinderivate und ihre verwendung in flüssigkristallinen mischungen | |
EP0824522B1 (de) | 1,8-difluorisochinolinderivate und ihre verwendung in flüssigkristallinen mischungen | |
DE19522195A1 (de) | Trifluornaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
EP0837851A1 (de) | Fluorierte phenanthren-derivate und ihre verwendung in flüssigkristallinen mischungen | |
EP0828716B1 (de) | Trifluortetrahydroisochinolin-derivate und ihre verwendung in flüssigkristallinen mischungen | |
EP0824520B1 (de) | 1-fluor-5,6,7,8-tetrahydroisochinolin-derivate und ihre verwendung in flüssigkristallinen mischungen | |
EP0637585A1 (de) | Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen | |
EP0824521B1 (de) | 1-fluor-6,7-dihydro-5h-isochinolin-8-on-derivate und ihre verwendung in flüssigkristallinen mischungen | |
WO1998027037A1 (de) | 1,3-difluornaphtalin-derivate fur flüssigkristallinen mischungen | |
DE19522167B4 (de) | 1,2-Difluornaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19522145B4 (de) | 7,8-Difluortetralin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
EP0946476B1 (de) | 5,7-difluor-1,2,3,4-tetrahydronaphthalin-derivate und ihre verwendung in flüssigkristallinen mischungen | |
DE19522152A1 (de) | Tetrafluortetralin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
EP0944690A1 (de) | 1,1,5,7-tetrafluor-1,2,3,4-tetrahydronaphthalin-derivate und ihre verwendung in flüssigkristallinen mischungen | |
WO1995021227A1 (de) | Phenanthridin-derivate und ihre verwendung in flüssigkristallinen mischungen | |
WO1998027038A1 (de) | 1,3,5-trifluornaphthalin-derivate für flüssigkristallinen mischungen | |
DE19522175A1 (de) | 7,8-Difluor-3,4-dihydro-2H-naphthalin-1-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19748438A1 (de) | 1,1,6,7-Tetrafluor-1,2,3,4-tetrahydronaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19748434A1 (de) | 7,8-Difluornaphthalin-1-carbonitril-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19748436A1 (de) | 5,7-Difluornaphthalin-1-carbonitril-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19748437A1 (de) | 6,7-Difluor-3,4-dihydro-2H-naphthalin-1-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19748435A1 (de) | 1,6,7-Trifluornaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen | |
DE19748433A1 (de) | 1-Fluor-isochinolin-8-carbonitril-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996916034 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08952054 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 533777 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970707992 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1996916034 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970707992 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996916034 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019970707992 Country of ref document: KR |